Want to create an interactive transcript for this episode?
Podcast: Nucleus Investment Insights
Episode: Ep.306 The Weight Is Over: Capitalising on the Booming Weight Loss Drug Industry | Nucleus Investment Insights
Description: Join us in this week's podcast as Nucleus Wealth's Chief Investment Officer Damien Klassen, Senior Investment Analyst Radek Zeleny, and Head of Advice Samuel Kerr dive deep into the fast-growing market of weight loss drugs, exploring the latest trends, breakthroughs, and market dynamics.
We provide an in-depth analysis of the top players in the industry, including established pharmaceutical giants and innovative startups that are shaking up the scene. Efficacy and safety of popular weight loss drugs, and what new treatments are on the horizon.
Next, we pull out the crystal ball and consider what other sectors may be impacted...